China Tian Yuan Healthcare Group Limited (HKG:0557)
Hong Kong · Delayed Price · Currency is HKD 0.7000
0.00 (0.00%)
At close: Feb 13, 2026
HKG:0557 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 20.42 | 26.85 | 45.23 | 54.22 | 94.59 | 56.34 | |
Revenue Growth (YoY) | -43.78% | -40.65% | -16.57% | -42.68% | 67.89% | -20.14% |
Cost of Revenue | 1.15 | 5.85 | 20.25 | 20.24 | 18.21 | 20.54 |
Gross Profit | 19.27 | 20.99 | 24.98 | 33.97 | 76.38 | 35.8 |
Selling, General & Admin | 33.89 | 31.1 | 40.75 | 56.63 | 90.03 | 84.17 |
Other Operating Expenses | -0.62 | - | - | - | - | - |
Operating Expenses | 28.43 | 28.36 | 47.8 | 56.58 | 93.8 | 79.16 |
Operating Income | -9.17 | -7.37 | -22.82 | -22.61 | -17.43 | -43.36 |
Interest Expense | -3.15 | -3.22 | -3.54 | -3.96 | -4.49 | -2.54 |
Interest & Investment Income | 0.77 | 0.74 | 0.15 | 0.03 | 0.01 | 0.12 |
Earnings From Equity Investments | -0.1 | -0.01 | -0.37 | 0.24 | 0.18 | 0.55 |
Currency Exchange Gain (Loss) | 2.1 | -2.51 | -3.9 | -5.03 | 1.07 | 7.19 |
Other Non Operating Income (Expenses) | 0.75 | 0.75 | 1.94 | 0.39 | 2.37 | -7.1 |
EBT Excluding Unusual Items | -8.8 | -11.63 | -28.54 | -30.93 | -18.28 | -45.13 |
Merger & Restructuring Charges | - | - | - | - | - | -0.53 |
Impairment of Goodwill | -23.47 | -23.47 | - | - | - | - |
Gain (Loss) on Sale of Investments | -2.64 | -3.26 | 1.7 | -6.93 | -0.67 | 0.33 |
Gain (Loss) on Sale of Assets | -0.07 | -0.07 | - | -0.02 | -0.11 | 0.11 |
Asset Writedown | - | - | -1.94 | -2.47 | - | -80.63 |
Pretax Income | -34.98 | -38.43 | -28.78 | -40.35 | -19.06 | -125.85 |
Income Tax Expense | 0.18 | 0.18 | -1.82 | - | - | -15.81 |
Earnings From Continuing Operations | -35.16 | -38.61 | -26.96 | -40.35 | -19.06 | -110.04 |
Net Income to Company | -35.16 | -38.61 | -26.96 | -40.35 | -19.06 | -110.04 |
Minority Interest in Earnings | 3.46 | 4.37 | 11.47 | 11.31 | 2.21 | 44.93 |
Net Income | -31.7 | -34.24 | -15.48 | -29.04 | -16.85 | -65.1 |
Net Income to Common | -31.7 | -34.24 | -15.48 | -29.04 | -16.85 | -65.1 |
Shares Outstanding (Basic) | 399 | 399 | 399 | 399 | 399 | 399 |
Shares Outstanding (Diluted) | 399 | 399 | 399 | 399 | 399 | 399 |
EPS (Basic) | -0.08 | -0.09 | -0.04 | -0.07 | -0.04 | -0.16 |
EPS (Diluted) | -0.08 | -0.09 | -0.04 | -0.07 | -0.04 | -0.16 |
Free Cash Flow | 11.92 | 10.67 | 4.51 | -31.71 | 14.86 | 52.25 |
Free Cash Flow Per Share | 0.03 | 0.03 | 0.01 | -0.08 | 0.04 | 0.13 |
Gross Margin | 94.35% | 78.19% | 55.24% | 62.66% | 80.75% | 63.54% |
Operating Margin | -44.88% | -27.45% | -50.45% | -41.70% | -18.42% | -76.96% |
Profit Margin | -155.22% | -127.54% | -34.23% | -53.56% | -17.82% | -115.55% |
Free Cash Flow Margin | 58.38% | 39.76% | 9.96% | -58.49% | 15.71% | 92.73% |
EBITDA | -6.77 | -5 | -19.21 | -18.63 | -13.02 | -26.7 |
EBITDA Margin | -33.13% | -18.63% | -42.47% | -34.37% | -13.77% | -47.38% |
D&A For EBITDA | 2.4 | 2.37 | 3.61 | 3.98 | 4.4 | 16.66 |
EBIT | -9.17 | -7.37 | -22.82 | -22.61 | -17.43 | -43.36 |
EBIT Margin | -44.88% | -27.45% | -50.45% | -41.70% | -18.42% | -76.96% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.